Previous 10 | Next 10 |
T2 Biosystems (TTOO) -20% despite strong Q4 & FY20 prelims.AIkido Pharma (AIKI) -18%.Seanergy Maritime Holdings (SHIP) -18%.Celsion CLSN -15%.Recon Technology (RCON) -15%.TransEnterix (TRXC) -14% after $69.25M capital raise.Ocugen (OCGN) -14%.BIOLASE (BIOL) -15%.P...
Gainers: [[BBBY]] +17.7%. [[IMMP]] +15.8%. [[FHTX]] +7.6%. [[TLSA]] +6.8%. [[ADMS]] +6.8%.Losers: [[TTOO]] -20.3%. [[VIR]] -17.0%. [[GRTX]] -16.6%. [[AGIO]] -8.4%. [[WMG]] -7.7%. For further details see: BBBY, IMMP, TTOO and VIR among after-hours movers
T2 Biosystems (TTOO) eroded 10% in after hours trade despite providing strong Q4 & FY20 prelims.Q4 total revenue is expected to be $7.8M, including product revenue of $5.8M, representing Y/Y growth of 155% and 274% respectively.FY20 revenue is seen at $18.1M (+118% Y/Y)."We saw ...
LEXINGTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a global leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and full year 2020. Financia...
T2 has been a huge beneficiary of the COVID-19 pandemic, as hospitals take a second look at its revolutionary diagnostic technology. A 300% revenue gain is projected by Wall Street for 2021 vs. 2019. Lower cash burn, potentially turning into cash flow from rising sales, may suppor...
Marathon Patent Group MARA -19% after $250M capital raise.Zomedica (ZOM) -16%.Asia Pacific Wire & Cable Corporation (APWC) -16%.Harbor Custom Development HCDI -13% after pricing stock offering.Party City Holdco PRTY -12% after Q4 guidance falls short.Borr Dri...
Shares of T2 Biosystems (NASDAQ: TTOO) are soaring through the roof on Tuesday, after the company announced good news regarding its T2SARS-CoV-2 Panel, a test kit that can detect the SARS-CoV-2 virus that causes COVID-19. The diagnostic test maker's stock is up by 15.9% as of 11:49 ...
La Jolla Pharmaceutical (LJPC) +62% on exclusive licensing agreement with PAIONVOXX International (VOXX) +56% after posting strong sales growth.T2 Biosystems (TTOO) +33% after the company says its T2SARS-CoV-2 Panel is capable of detecting multiple variants of the COVID-19 viru...
T2 Biosystems (TTOO) +36.8% post-market after saying its T2SARS-CoV-2 Panel is capable of detecting multiple variants of the COVID-19 virus most recently identified in the U.K., South Africa and the U.S.The company says an analysis showed its T2SARS-CoV-2 Panel should detect 99.99% of all SAR...
Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S. LEXINGTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsi...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial and operational results for the second quarter ended Jun...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Malaysia and Indonesia. Under the ter...
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after mar...